Adaptive Biotechnologies (ADPT) EBIT Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -31.42% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 6.03% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -3.96% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 8.95% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.37% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 2.95% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 12.23% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 73.97% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -3.05% |
| 10 | Adaptive Biotechnologies | 2.60 Bn | 2.39 Bn | 52.17 Mn | 30.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.49% |
| Dec 31, 2025 | 31.18% |
| Sep 30, 2025 | 30.58% |
| Jun 30, 2025 | 21.87% |
| Mar 31, 2025 | 22.28% |
| Dec 31, 2024 | 18.10% |
| Sep 30, 2024 | 16.64% |
| Jun 30, 2024 | 1.67% |
| Mar 31, 2024 | -5.71% |
| Dec 31, 2023 | -17.12% |
| Sep 30, 2023 | -11.21% |
| Jun 30, 2023 | -9.02% |
| Mar 31, 2023 | -18.21% |
| Dec 31, 2022 | -17.45% |
| Sep 30, 2022 | -36.02% |
| Jun 30, 2022 | -48.28% |
| Mar 31, 2022 | -46.53% |
| Dec 31, 2021 | -63.30% |
| Sep 30, 2021 | -83.20% |
| Jun 30, 2021 | -55.20% |